Pharmacovigilance in Hungary
How is it with the drug safety system in the “Land of Thermal Baths”? Read our guide to get a clear picture.
And of course, if you feel you need a local consultant, we’re here for you.
Current status of our Hungarian pharmacovigilance services:
LCPPV / EU QPPV in Hungary
AVAILABLE
Easily managed through Tepsivo Platform >
Local Literature Screening
AVAILABLE
Automated monitoring with Tepsivo Literature >
Who is the main PV authority in Hungary?
Other important institutions & industry groups
Some of the most important laws
Essential EU Legislation and EMA Guidlines
Since Estonia is a member of the EU, every Marketing Authorization Holder with a product on the Estonian market needs to follow the European pharmacovigilance legislation and guidelines by EMA (European Medicine Agency).
To navigate through the European regulations, its is useful to know following:
– EMA Pharmacovigilance System Manual
– Directive 2001/83/EC
– Regulation (EC) 726/2004
– Commission Implementing Regulation (EU) 520/2012
Local pharmacovigilance specifics
Useful abbreviations to know
If you want to study local materials about pharmacovigilance in Hungary, following terms will be helpful for you to get familiar with:
EMA (European Medicine Organization)
→ Key part of the EU, dedicated to ensuring the safety and effectiveness of medicines.
EVPM (EudraVigilance post-authorization module)
→ Dedicated to the collection of ICSRs related to all medicinal products authorised in the EEA.
PRAC (Pharmacovigilance Risk Assessment Committee)
→ Committee responsible for assessing and monitoring the safety of human medicines
NNGYK (Nemzeti Népegészségügyi és Gyógyszerészeti Központ)
→ National Center for Public Health and Pharmacy / Main authority on pharmacovigilance.
OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet)
→ National Institute of Pharmacy and Nutrition
Is LCPPV needed or is EU QPPV enough?
How can be adverse events reported in Hungary?
Reports can be submitted by healthcare professionals, patients, or anyone who observes an adverse drug reaction. Adverse drug reactions should be reported to the NNGYK, you can do so via this site.
The reports can be also submitted electronically using the EudraVigilance system.
Local medical journals to screen
Here are few examples of Hungarian local literature sources that medical authorization holders should monitor:
ORVOSI HETILAP
One of Hungary’s oldest medical journals, publishing peer-reviewed articles on various medical topics, including pharmacovigilance.
It offers a comprehensive view of current medical practices and research, making it essential for healthcare professionals.
ISSN: 1788-6120
MAGYAR BELORVOSI ARCHÍVUM
This journal publishes original research articles, case studies, and reviews in the field of internal medicine, offering a platform for sharing clinical findings and advancements.
It is particularly valuable for healthcare professionals interested in the latest developments in pharmacovigilance and patient safety within internal medicine.
ISSN: 0025-0066
ACTA PHARMACEUTICA HUNGARICA
It focuses on pharmaceutical sciences, including drug development, pharmacology, and pharmacovigilance.
It is essential for researchers and professionals interested in the latest advancements in pharmaceuticals and drug safety.
ISSN: 1587-1495
Rather then spending your budget for hours of repetitive manual work to monitor those sources, we recommend to simply automate this task using our Tepsivo Literature solution.
Other interesting resources
Hungary: Country Health Profile
The 2023 editions provide a comprehensive look at the health landscape in the country, exploring key topics such as overall health status, important health determinants and risk factors, and how the health system is organized and funded.
Scientific publications regarding pharmacovigilance
Overview of the causes and management of drug shortages in the United States and in Hungary
You’ll discover how the alarming rise in drug shortages is not just a local issue in Hungary but a global health crisis affecting patients everywhere. The authors delve into the root causes of these shortages and propose actionable solutions.
Dive into the complex world of the pharmaceutical supply chain, revealing how globalization and trade practices have made it easier for counterfeit medicines. Readers will uncover the financial implications of anti-falsification measures, the challenges faced by hospital pharmacies in implementing new regulations, and more.
Interesting resources
This page contains basic staticsits about Hungary in various fields such as Population, Life expectancy or Health statistics.
Do you need some help with putting the Hungarian PV System together? We’re here for you.
And while you’re here…
…consider also our global end-to-end PV solution!
Thanks to the Tepsivo platform, you can get a full pharmacovigilance system in all countries you need – for a fraction of the usual budget.
Tepsivo Oy | Urho Kekkosen katu, 4-6 E, 00 100, Helsinki, Finland | VAT number FI31367614 | contact@tepsivo.com | +358 402 204 698 | Privacy policy













